Seeking Alpha

More on McKesson's FQ3: The company expects FY12 EPS of $6.19-$6.39, compared with a $6.33...

More on McKesson's FQ3: The company expects FY12 EPS of $6.19-$6.39, compared with a $6.33 consensus. It's also acquiring Drug Trading Company Ltd., the "marketing and purchasing arm" for a network of over 850 Canadian pharmacies, and Medicine Shoppe, a provider of services to over 160 Canadian pharmacies, from Katz Group. The deal will cost ~$918M in cash. MCK +3.3% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector